Preclinical evaluation of MVA as vaccine against monkeypox virus (MKPXV) experimental infection in cynomolgus macaques
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ANRS0298
Grant search
Key facts
Disease
mpoxStart & end year
2022Known Financial Commitments (USD)
$309,699.91Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Principal Investigator
TOURNIER Jean-NicolasResearch Location
FranceLead Research Institution
Institut de Recherche Biomédical des ArméesResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Mpox Research Priorities
Vaccines research, development and implementation
Mpox Research Sub Priorities
Development of equitable, accessible, safe and effective vaccines
Abstract
N/A